Riga, Latvia

Inese Reine

This inventor holds 5 USPTO granted patents and 2 published patent applications, plus 3 CIPO patents and 5 EPO patents. Top assignees: Integrative Research Laboratories Sweden Ab, Jsc Grindeks, Irl 790 Ab. Active years: 2011-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Inese Reine. Retrieved from https://idiyas.com/inventor/inese-reine

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2011-2025

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Inese Reine - Innovator in Pharmaceutical Chemistry

Introduction

Inese Reine is a prominent inventor based in Riga, Latvia, known for her significant contributions to pharmaceutical chemistry. With a total of five patents to her name, she has made notable advancements in the field of drug formulation and development.

Latest Patents

Her latest patents include innovative compounds such as pharmaceutically acceptable salts of [2-(3-fluoro-5-methane-sulfonylphenoxy)ethyl](propyl)amine, which details a method for manufacturing these salts and their various uses. Another significant patent involves (+)-3-(2,3-difluorophenyl)-3-methoxypyrrolidine and its pharmaceutically acceptable salts, along with a process for their preparation and applications.

Career Highlights

Inese has worked with reputable companies such as JSC Grindeks and Integrative Research Laboratories Sweden AB, where she has applied her expertise in pharmaceutical research and development. Her work has contributed to the advancement of new therapeutic options in the market.

Collaborations

Throughout her career, Inese has collaborated with notable professionals in her field, including Clas Sonesson and Armands Zandersons. These partnerships have fostered innovation and enhanced the quality of her research.

Conclusion

Inese Reine continues to be a driving force in pharmaceutical innovation, with

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…